FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Hydroxypropyl (Lacrisert) Cellulose Ophthalmic Insert
Status: Currently in Shortage
»Date first posted: 05/01/2020
»Therapeutic Categories: Ophthalmology

Bausch Health Americas, Inc. (Revised 09/08/2021)

Company Contact Information:

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Lacrisert, 5 mg per ophthalmic insert, 60 unit dose blister pack (NDC 24208-800-60) Unavailable, Resupply expected February 2022 Other

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English